Data from EMC - Curated by Toby Galbraith - Last updated 15 March 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

Treatment of essential hypertension.

Copalia is indicated in adults whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Bedwetting

Essential screening, diagnosis and best strategies to manage bedwetting

Visit Bedwetting

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation

More information

Category Value
Agency product number EMEA/H/C/000774
Orphan designation No
Date First Approved 16-01-2007
Type POM
Marketing authorisation holder Novartis Europharm Ltd

Related Content